Published April 28, 2026
| Version v1
Journal article
Open
Evaluating the consistency of ANA results: A cross-method study of three immunodiagnostic techniques
Authors/Creators
- 1. Sofia University "St. Kliment Ohridski", Sofia, Bulgaria
- 2. Medical-Diagnostic Laboratory Ramus ltd., Sofia, Bulgaria
- 3. Specialized Hospital for Active Treatment of Infectious and Parasitic Diseases, Sofia, Bulgaria
- 4. Medical-Diagnostic Laboratory Ramus ltd., Sofia, Bulgaria|Medical College "Yordanka Filaretova", Sofia, Bulgaria
Description
Objectives: Indirect immunofluorescence (IIF) on HEp-2 cells is the gold standard for antinuclear antibody (ANA) screening, followed by antigen-specific confirmation using immunoassays such as immunoblot (IB) and ELISA. This study aimed to compare antigen-specific ANA/ENA results obtained by these three methods.
Materials and methods: Serum samples from 100 individuals (mean age 47 years; 12 men, 88 women) were analyzed. ANA screening was performed by IIF on HEp-2 cells (ANA-HEp-2, ByoSystems) using a EUROStar III Plus fluorescence microscope; titers >1:80 were considered positive. IB was performed using ANA Profile 3 plus DFS70 (EUROIMMUN). ELISA testing included SS-A, SS-B, Scl-70, and dsDNA-NcX (EUROIMMUN), and RNP/Sm, Jo-1, and AMA-M2 (Orgentec).
Results: Based on IIF, participants were classified as ANA-positive (n = 48), borderline (n = 26), or ANA-negative (n = 26). The most frequent IB reactivities were SS-A, Ro-52, centromere B, and AMA-M2. In ANA-negative and borderline groups, IB signal intensity >20 was detected for SS-A (n = 2), Ro-52 (n = 4), and Scl-70 (n = 3). Among ANA-positive individuals, ICAP pattern interpretation showed concordance with IB in 40 cases and discordance in two cases. Agreement between ELISA and IB varied by antigen (50%–88%), with the highest concordance for SS-A. Correlation between IB and ELISA ranged from moderate to very strong (r = 0.5–>0.9).
Conclusion: IIF, IB, and ELISA provide complementary information, with variable sensitivities and clinically relevant agreement, underscoring the need for a structured diagnostic algorithm combined with clinical context.
Files
PHAR_article_167651.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:ac6ff402cb0f519b93567ec6470539ec
|
1.0 MB | Preview Download |
|
md5:3abd882b1d4d6164cb28dc5609dcfac5
|
79.6 kB | Preview Download |
Additional details
References
- Alsaed OS, Alamlih LI, Al-Radideh O, Chandra P, Alemadi S, Al-Allaf AW (2021) Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases. Scientific Reports 11: e8229. https://doi.org/10.1038/s41598-021-87366-w
- Andrade LEC, Klotz W, Herold M, Musset L, Damoiseaux J, Infantino M, Carballo OG, Choi M, von Mühlen CA, Garcia-De La Torre I, Satoh M, Francescantonio PLC, Mimori T, Conrad K, de Melo Cruvinel W, Chan EKL, Fritzler MJ (2024) Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshop. Autoimmunity Reviews 23(9): e103608. https://doi.org/10.1016/j.autrev.2024.103608
- Carbone T, Gilio M, Padula MC, Tramontano G, D'Angelo S, Pafundi V (2018) A step towards standardization: A method for end-point titer determination by fluorescence index of an automated microscope. Journal of Immunological Methods 456: 67–71. https://doi.org/10.1016/j.jim.2018.02.014
- Castro C, Gourley M (2010) Diagnostic testing and interpretation of tests for autoimmunity. Journal of Allergy and Clinical Immunology 125(2 Suppl 2): S238–S247. https://doi.org/10.1016/j.jaci.2009.09.041
- Chan EKL, von Mühlen CA, Fritzler MJ, Damoiseaux J, Infantino M, Klotz W, Satoh M, Musset L, García-De La Torre I, Carballo OG, Herold M, de Melo Cruvinel W, Mimori T, Andrade LEC (2022) The International Consensus on ANA Patterns (ICAP) in 2021: The 6th workshop and current perspectives. Journal of Applied Laboratory Medicine 7(1): 322–330. https://doi.org/10.1093/jalm/jfab140
- Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, Garcia de la Torre I, Herold M, Klotz W, Cruvinel WM, Mimori T, von Muhlen C, Satoh M, Chan EK (2019) Clinical relevance of HEp-2 indirect immunofluorescent patterns: The International Consensus on ANA patterns (ICAP) perspective. Annals of the Rheumatic Diseases 78(7): 879–889. https://doi.org/10.1136/annrheumdis-2018-214436
- Dinse GE, Parks CG, Meier HCS, Co CA, Chan EKL, Jusko TA, Yeh J, Miller FW (2018) Prescription medication use and antinuclear antibodies in the United States, 1999–2004. Journal of Autoimmunity 92: 93–103. https://doi.org/10.1016/j.jaut.2018.05.006
- González Rodríguez C, Fuentes Cantero S, Pérez Pérez A, Vázquez Barbero FJ, León Justel A (2021) Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening. Journal of Clinical Laboratory Analysis 35(9): e23914. https://doi.org/10.1002/jcla.23914
- Grygiel-Górniak B, Rogacka N, Puszczewicz M (2018) Antinuclear antibodies in healthy people and non-rheumatic diseases: Diagnostic and clinical implications. Reumatologia 56(4): 243–248. https://doi.org/10.5114/reum.2018.77976
- Im JH, Chung MH, Park YK, Kwon HY, Baek JH, Lee SY, Lee JS (2020) Antinuclear antibodies in infectious diseases. Infectious Diseases 52(3): 177–185. https://doi.org/10.1080/23744235.2019.1690676
- Irure-Ventura J, López-Hoyos M (2022) The past, present, and future in antinuclear antibodies (ANA). Diagnostics 12(3): e647. https://doi.org/10.3390/diagnostics12030647
- Jang J, Kim S, Kim HS, Lee KA, Park J, Park Y (2021) Comparison of antinuclear antibody profiles obtained using line immunoassay and fluorescence enzyme immunoassay. Journal of International Medical Research 49(6): e3000605211014390. https://doi.org/10.1177/03000605211014390
- Kraev K, Hristov B, Uchikov P, Kraeva M, Basheva-Kraeva Y, Valova S, Koleva-Ivanova M, Popova-Belova S, Sandeva M, Chakarov D, Geneva-Popova M (2024) Comprehensive exploration of antinuclear antibodies (ANAs): Unveiling clinical significance, associations with cancer, and the nuances of differential diagnosis in positive ANA patients. Diagnostics 14(3): e320. https://doi.org/10.3390/diagnostics14030320
- Kumar NN, Ahmad Dit Al Hakim S, Grygiel-Górniak B (2025) Antinuclear antibodies in non-rheumatic diseases. Archivum Immunologiae et Therapiae Experimentalis 73(1). https://doi.org/10.2478/aite-2025-0004
- Kutlu Ö, Çetinkaya P, Şahin T, Ekşioğlu HM (2020) The effect of biological agents on antinuclear antibody status in patients with psoriasis: A single-center study. Indian Dermatology Online Journal 11(6): 904–909. https://doi.org/10.4103/idoj.IDOJ_164_20
- Li Z, Han R, Yan Z, Li L, Feng Z (2019) Antinuclear antibodies detection: A comparative study between automated recognition and conventional visual interpretation. Journal of Clinical Laboratory Analysis 33(1): e22619. https://doi.org/10.1002/jcla.22619
- Murdjeva MA, Ryasheva NP, Draganov MM, Paunov LD (2011) A comparative study of immunological methods for determination of serum antinuclear antibodies. Folia Medica 53(4): 21–27. https://doi.org/10.2478/v10153-011-0063-0
- Nakano K, Fujita S, Hiramatsu-Asano S, Nagasu A, Tsuji S, Koide Y, Yamada M, Mizuta Y, Ikeda M, Hirano H, Morita Y (2025) Clinical significance of antinuclear antibodies in patients with rheumatoid arthritis: From SETOUCHI-RA registry. Journal of Clinical Medicine 14(5): e1553. https://doi.org/10.3390/jcm14051553
- Nosal RS, Superville SS, Amraei R, Varacallo MA (2025) Biochemistry, Antinuclear Antibodies (ANA). StatPearls [Internet]. Treasure Island (FL), StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK537071/
- Öztürk Ö, Dos Santos Duarte SD, Balaban HY, Şimşek H, Şener B (2022) Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies. Turkish Journal of Medical Sciences 52(5): 1697–1703. https://doi.org/10.55730/1300-0144.5512
- Robbins A, Hentzien M, Toquet S, Didier K, Servettaz A, Pham BN, Giusti D (2019) Diagnostic utility of separate anti-Ro60 and anti-Ro52/TRIM21 antibody detection in autoimmune diseases. Frontiers in Immunology 10: e444. https://doi.org/10.3389/fimmu.2019.00444
- Sarafian V, Murdjeva M, Draganov M, Ganchevska P (2004) Comparative analysis of immunoperoxidase and immunofluorescent assays on different substrates for screening antinuclear antibodies. Trakia Journal of Sciences 2(1): 7–11.
- Turan Faraşat V, Ecemiş T, Doğan Y, Şener AG, Terek Ece G, Dündar PE, Şanlidağ T (2019) A multicenter analysis of subjectivity of indirect immunofluorescence test in antinuclear antibody screening. Archives of Rheumatology 34(3): 326–333. https://doi.org/10.5606/ArchRheumatol.2019.7310
- Vlagea A, Falagan S, Gutiérrez-Gutiérrez G, Moreno-Rubio J, Merino M, Zambrana F, Casado E, Sereno M (2018) Antinuclear antibodies and cancer: A literature review. Critical Reviews in Oncology/Hematology 127: 42–49. https://doi.org/10.1016/j.critrevonc.2018.05.002
- Yang HT, Hong XP, Guo JW, Zhong XL, Liao R, Liu CL, Liu LX, Li K, Chen YL, Liu DZ (2023) Clinical significance of different profiles of anti-Ro antibodies in connective tissue diseases. Journal of Immunology Research: e9195157. https://doi.org/10.1155/2023/9195157
- Zagorov M, Draganov M, Alimanska S, Staykova N, Trayancheva M, Murdjeva M (2006) Diagnostic performance for rheumatoid arthritis of the indirect immunofluorescent assay for antinuclear antibodies on McCOY-PLOVDIV serum-free cell line and HEp-2 cell line substrates. Revmatologia 14(2): 25–27. https://doi.org/10.1016/j.cimid.2006.11.007
- Zagorov M, Draganov M, Fransazov S, Trayancheva M, Sarafian V, Murdjeva M (2005) Antinuclear antibodies in Bulgarian patients with chronic infections. In: Gruev B, Nikolova M, Donev A (Eds) Proceedings of the Balkan Scientific Conference of Biology, 2005 May 19–21. University of Plovdiv, Plovdiv, 246–252.